DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Wedbush Maintains Outperform on Biohaven Pharmaceutical, Raises Price Target to $78

Wedbush maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Outperform and raises the price target from $73 to $78.

Benzinga · 03/13/2020 12:48

Wedbush maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Outperform and raises the price target from $73 to $78.